CLS Holdings USA Inc. Begins Trading Publicly Under Symbol “CLSH”

Setting Out to Create the Gold National Standard Brand in the Evolving Cannabis Industry

BOULDER, CO / ACCESSWIRE / April 30, 2015 / CLS Holdings USA, Inc. (OTC: CLSH), a diversified cannabis company, today announced the commencement of trading under the ticker symbol “CLSH” effective April 30, 2015. Additional information on this transaction can be found in the company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 30, 2015. 

http://www.sec.gov/Archives/edgar/data/1522222/000118518515001059/cls8k042415.htm

CLS Holdings USA business model includes licensing operations, processing revenue, processing facilities, sale of products and brand creation and consulting services. CLS stands for “Cannabis Life Sciences,” as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. The Company mission is to be the industry leader in the extraction, conversion and marketing of cannabinoid oils, wax, edibles and shatter by leveraging our extraction methods and conversion processes.

For the past two years, one of the founders of CLS has been developing a proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes (“e-cigarettes”), and used for a variety of pharmaceutical and other purposes. Internal testing of this extraction method and conversion process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace. 

Mr. Jeff Binder, Chairman, President and Chief Executive Officer of CLS Holdings USA Inc., commented, “Our vision is to accelerate cannabis extraction and conversion through proprietary methods while increasing quality and volume in a compliance, testing and standardization environment. We are excited by our progress to-date as we look to take advantage of the emerging legalized cannabis industry in which the market is projected to grow annually by 27% over the next three years to an expected market value greater than $8B by the end of 2018. We are thrilled to now be a publicly-traded company and look forward to reporting our progress with shareholders and the Wall Street community.”

We have an experienced team of executives and consultants who each contribute significant value in the scientific, marketing and licensure arenas. Jeffrey Binder, a founder of CLS Labs and our Chairman, President and Chief Executive Officer, is a seasoned executive with experience in the strategic start-up and growth of companies in several different industries. Raymond Keller, a founder of CLS Labs, developed the aforementioned proprietary process of extracting, cleaning and converting the cannabinoids from the cannabis plant and the associated delivery materials and systems for such cannabinoids. Michael Abrams, our Chief Operating Officer, has significant experience in the medical marijuana consulting business, including executive level experience in the cannabinoid extraction business and other cannabis related ventures. Frank Koretsky, a founder of CLS Labs and director of the Company, is a successful entrepreneur who has proven to be a marketing and brand specialist.

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. is a diversified cannabis company, specializing in the extraction and conversion of cannabinoids. CLS stands for “Cannabis Life Sciences,” as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. CLS Holdings USA business model includes licensing operations, processing revenue, processing facilities, sale of products and brand creation and consulting services.

For more information, check out: http://www.clsholdingsinc.com.

Forward-Looking Statements

Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Form 8-K filed on April 30, 2015, including but not limited to the discussion under “Risk Factors” therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.

Contact Information

Corporate:
Chairman and CEO
Jeff Binder
jeff@clsholdingsusa.com
888-438-9132

Investors:
Hayden IR
Brett Maas
brett@haydenir.com
646-536-7331

SOURCE: CLS Holdings USA, Inc.

ReleaseID: 428370